10-K/A

AMENDMENT NO. 2 TO FORM 10-K

Company: Jasper Therapeutics, Inc.
Filed: July 19, 2021
Period of Report: December 31, 2020
Accession Number: 0001213900-21-037315

View Document ↗ View on SEC.gov ↗